Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells.

Lee AW, Hertel L, Louie RK, Burster T, Lacaille V, Pashine A, Abate DA, Mocarski ES, Mellins ED.

J Immunol. 2006 Sep 15;177(6):3960-71.

2.

Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels.

Lee AW, Wang N, Hornell TM, Harding JJ, Deshpande C, Hertel L, Lacaille V, Pashine A, Macaubas C, Mocarski ES, Mellins ED.

Mol Immunol. 2011 May;48(9-10):1160-7. doi: 10.1016/j.molimm.2011.02.010. Epub 2011 Mar 31.

3.

Human cytomegalovirus disrupts constitutive MHC class II expression.

Cebulla CM, Miller DM, Zhang Y, Rahill BM, Zimmerman P, Robinson JM, Sedmak DD.

J Immunol. 2002 Jul 1;169(1):167-76.

5.

Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels.

Kessler T, Reich M, Jahn G, Tolosa E, Beck A, Kalbacher H, Overkleeft H, Schempp S, Driessen C.

J Gen Virol. 2008 Oct;89(Pt 10):2427-36. doi: 10.1099/vir.0.2008/001610-0.

PMID:
18796710
6.

Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.

Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ.

J Immunol. 2003 Dec 15;171(12):6757-65.

8.

HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.

Mann DL, Read-Connole E, Arthur LO, Robey WG, Wernet P, Schneider EM, Blattner WA, Popovic M.

J Immunol. 1988 Aug 15;141(4):1131-6.

PMID:
2840463
9.

Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors.

Slobedman B, Mocarski ES, Arvin AM, Mellins ED, Abendroth A.

Blood. 2002 Oct 15;100(8):2867-73.

10.

Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.

Tomazin R, Boname J, Hegde NR, Lewinsohn DM, Altschuler Y, Jones TR, Cresswell P, Nelson JA, Riddell SR, Johnson DC.

Nat Med. 1999 Sep;5(9):1039-43.

PMID:
10470081
11.

Conformational variation of surface class II MHC proteins during myeloid dendritic cell differentiation accompanies structural changes in lysosomal MIIC.

Potolicchio I, Chitta S, Xu X, Fonseca D, Crisi G, Horejsi V, Strominger JL, Stern LJ, Raposo G, Santambrogio L.

J Immunol. 2005 Oct 15;175(8):4935-47.

13.

Down-regulation of HLA-G1 cell surface expression in human cytomegalovirus infected cells.

Pizzato N, Garmy-Susini B, Le Bouteiller P, Lenfant F.

Am J Reprod Immunol. 2003 Oct;50(4):328-33.

PMID:
14672336
14.

Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.

Terauchi M, Koi H, Hayano C, Toyama-Sorimachi N, Karasuyama H, Yamanashi Y, Aso T, Shirakata M.

J Virol. 2003 Aug;77(15):8187-95.

16.
17.

Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.

Johnson DC, Hegde NR.

Curr Top Microbiol Immunol. 2002;269:101-15. Review.

PMID:
12224504
18.

Differential modulation of human epidermal Langerhans cell maturation by ultraviolet B radiation.

Nakagawa S, Koomen CW, Bos JD, Teunissen MB.

J Immunol. 1999 Nov 15;163(10):5192-200.

19.

Residual expression of functional MHC class II molecules in twin brothers with MHC class II deficiency is cell type specific.

Wolf HM, Thon V, Gulle H, Lechleitner S, Eibl MM, Petzelbauer P.

Br J Haematol. 2001 Nov;115(2):460-71.

PMID:
11703350

Supplemental Content

Support Center